Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival? https://t.co/MoWbQxvZ9v https://t.co/QSxu8xGXJ2
17,936 followers
17,936 followers
Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?: Background Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic… #oncology https://t.co/jq
6,544 followers
New research: Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?: Background Pancreatic ductal adenocarcinoma (PDAC) is the most common pancreatic… https://t.c